ASH 2010 Conference Coverage

Engineered Switch in Immune Cell Technology Makes Therapy More Precise, and Safer

Researchers engineered a molecular on switch that allows tight control over the actions of T cells, laying the groundwork for sharply reducing the side effects of T cell-based treatments.

Testosterone Therapy Does Not Increase Aggressive Prostate Cancer Risk

Use of testosterone therapy has increased in the last decade and the potential long-term risks associated with this therapy have been of concern.

Laparascopic Surgery Does Not Improve Outcomes Over Open Resection for Rectal Cancer

Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer.

Bisphosphonates May Be Useful as Palliative Measure in Selected Patients

Bisphosphonates may improve symptoms of hypercalcemia and prolong survival in patients receiving palliative care.

Smokers and Nonsmokers Who Develop NSCLC Display Differences

Nonsmokers more likely than smokers to be women and to have adenocarcinoma

Newly Identified Gene Mutations May Expand Indications for Existing Targeted Cancer Treatments

Researchers identified two new cancer-causing gene mutations that could lead to more targeted and effective treatments for certain lung and prostate cancers.

Clinical Trial Populations May Not Represent Patients Using Studied Medications

A recent study showed that for certain cancer drugs, participants in clinical trials are often not representative of the patients who ultimately take the drugs, raising questions about the direct applicability of trial data.

They Asked You: Conversations at the Cancer Patient's Bedside

Patients' constant proximity to nurses gives them opportunities and the ease of familiarity to ask difficult questions. When answering, nurses should remember that part of the answer is the patient's choice of who to ask.

Two-Drug Combination Shows Promise Against One Type of Pancreatic Cancer

Researchers have shown that a certain protein becomes overabundant in pancreatic neuroendocrine tumors, allowing them to thrive. They also found that pairing a synthetic compound with an existing drug provides a more effective anticancer punch than a single drug.

MS Pain Management in Patients With Cancer

What are the most effective treatments for MS pain in patients with co-existing cancer?

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs